NCT03502161终止不适用
Clinical Evaluation of the QuantiFERON CMV Assay
QIAGEN Gaithersburg, Inc1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2018年11月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- Change in time to CMV Infection between sub-groups of QF-CMV assay classifications.
研究概览
简要总结
Validate the use of the device in the clinical setting for assessing the risk of CMV Infection in SOT recipients after the completion of antiviral prophylaxis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult CMV D+/R- liver, kidney, heart, pancreas, lung, intestinal, or combined transplant recipients that are 18 years of age or older.
- •Scheduled to receive between 3 to 6 months of antiviral prophylaxis
- •Provide Informed Consent
排除标准
- •Subjects less than 18 years old
- •Scheduled to receive longer than 6 months or shorter than 3 months of prophylaxis
- •Unable to provide Informed Consent
结局指标
主要结局
Change in time to CMV Infection between sub-groups of QF-CMV assay classifications.
时间窗: At time of prophylaxis termination, +1 month from termination, +2 months from termination
Measurement of QF-CMV result
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)Cytomegalovirus InfectionsHeart TransplantationKidney TransplantationLung TransplantationLiver TransplantationNCT06341543University Hospital, Grenoble288
Unknown
不适用
Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMVCytomegalovirus InfectionsCMVKidney Transplant InfectionNCT03858907University of Sao Paulo General Hospital180
已完成
不适用
Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant RecipientsImmunity, CellularNCT02560857Deepali Kumar151
终止
不适用
Clinical Performance Evaluation of DxN CMV AssayCytomegalovirusNCT03127787Beckman Coulter, Inc.19
已完成
不适用
Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant RecipientsCytomegalovirus InfectionNCT00817908University of Alberta131